MyAverix Finance
F · Healthcare
GRIFOLS ADR 1/2/EO-50 (G0F)
Drug Manufacturers - General
GRIFOLS ADR 1/2/EO-50 (G0F) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-29, reported market cap is $5.55B, P/E ratio is 15.11, net margin is 5.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for G0F
GRIFOLS ADR 1/2/EO-50 (G0F) — FAQ
What is GRIFOLS ADR 1/2/EO-50's market cap?
GRIFOLS ADR 1/2/EO-50 (G0F) has a reported market cap of $5.55B (data as of 2026-03-29).
What is G0F's P/E ratio?
The price-to-earnings (P/E) ratio for GRIFOLS ADR 1/2/EO-50 (G0F) is 15.11 (data as of 2026-03-29).
Does GRIFOLS ADR 1/2/EO-50 pay a dividend?
Dividend yield is not available in the current snapshot for GRIFOLS ADR 1/2/EO-50 (G0F). Check the MyAverix Finance app for the latest dividend data.
What sector is GRIFOLS ADR 1/2/EO-50 in?
GRIFOLS ADR 1/2/EO-50 (G0F) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is G0F listed on?
G0F is listed on F.
What is GRIFOLS ADR 1/2/EO-50's net margin?
GRIFOLS ADR 1/2/EO-50 (G0F) reports a net margin of 5.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.